NY Latest To Challenge $55M Schering Deal
Yet another entity has taken issue with a settlement in which Schering-Plough Corp. and its generics subsidiary Warrick Pharmaceuticals Corp. agreed to pay $55 million to resolve several lawsuits alleging that...To view the full article, register now.
Already a subscriber? Click here to view full article